Moderator: John G. Finkenberg, MD
62. Trends in Lumbar Fusion Procedure Rates and Associated Hospital Costs for Degenerative Spinal Diseases in the United States, 2004-2013
Brook I. Martin, PhD, MPH
63. Assessing Variation in Cost- and Episode-Based Outcomes Between Surgical Services for Patients Undergoing Posterior Lumbar Fusion
Daniel J. Snyder, BS
64. Propensity-Matched Index Episode of Care Cost Comparison Between Minimally Invasive Midline Lumbar Interbody Fusion (MIDLIF) versus Traditional Open Transforaminal Interbody Fusion (tLIF)
Jeffrey L. Gum, MD
65. Cost Effectiveness of Vancomycin Powder in Lumbar Laminectomy
Gregory J. Kirchner, MPH
66. Cost-Benefit Analysis of Intraoperative EMG for Pedicle Screw Placement in Routine Lumbar Fusions
Kirk Owens II, MD
67. The Impact of Diabetes Mellitus on Length of Stay and Direct Hospital Costs after Minimally Invasive Transforaminal Lumbar Interbody Fusion
Dil Patel, BS
68. Iliac Crest Bone Graft for Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Prospective Analysis of Inpatient Pain, Narcotics Consumption and Costs
Mundeep Bawa, BA
Discussion